abstract |
A formulation comprises a plurality of seamless minicapsules, the minicapsules having a diameter of from 0.5 mm to 5 mm, the minicapsules having a core containing an active entity and an encapsulating body, the active entity being in the form of any one or more of:- n• a microemulsion, n• a nanoemulsion, n• a self-emulsifying delivery system, n• a self-microemulsifying delivery system, n• a biostable perflurocarbon formulation, n• a complex with cyclodextrin (and the like), n• liposomes, n• hydrogel, n• lymphatic targeted delivery system, n• liquid bi-layers, n• an aqueous system, n• wax, n• emzaloid, and n• natural plant extract. |